Living with Type 2 Diabetes and recently diagnosed with cancer or heart failure after taking Onglyza™? You may receive compensation for your injuries. Contact an Onglyza lawyer today for a free confidential case evaluation, to see if you may qualify to file a suit against AstraZeneca, the manufacturers of Onglyza (saxagliptin).
What is Onglyza?
Onglyza is an incretin mimetic medicine that is used for the treatment of Type 2 Diabetes. The drug mimics a hormone that your body produces naturally to regulate the amount of insulin released into your system after a meal. Health care providers have prescribed Onglyza to adults with type 2 diabetes to help lower blood sugar levels.
A major user risk associated with this drug: a 27% increased risk of hospitalization for congestive heart failure. After the New England Journal of Medicine (NEJM) published these clinical study findings, the Food and Drug Administration (FDA) recommended in April 2015 that Onglyza labeling updated to warn against heart failure and also, death risk.
Heart Failure Side Effects
Heart failure side effects include:
- Congested lungs
- Also, extreme fluid retention
- Increased need to urinate
- Also, dizziness
- Rapid heartbeat
- Irregular heartbeat
If you or a loved one is currently taking Onglyza and experiencing any of these side effects, you should immediately seek medical attention.
AstraZeneca is alleged to have unnecessarily placed diabetic patients in inherent danger by failing to:
- Adequately warn doctors about potential side effects
- Also, adequately warn patients about potential side effects
- Conduct sufficient pre-market trials
- Properly market the drug
Our Onglyza lawyer currently assesses potential legal claims for adults with type 2 diabetes who have used Onglyza and also, suffered heart complications. Contact us today. So, don’t wait!